Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Dechra Pharmaceuticals plc    DPH   GB0009633180

Delayed Quote. Delayed  - 10/20 05:35:01 pm
2050 GBp   -1.20%
10/20 DECHRA PHARMACE : Result of AGM - 20 October 2017
10/20 DECHRA PHARMACE : Pre Annual General Meeting Statement
09/19 DECHRA PHARMACE : Annual Financial Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on DECHRA PHARMACEUTICALS PLC
10/26/17 ex-dividend day for final dividend
11/09/17 Vets Now ECC Conference
02/27/18 Interim 2018 Earnings Release (Projected)
09/04/18 FY 2018 Earnings Release (Projected)
Past events on DECHRA PHARMACEUTICALS PLC
10/20/17 | 02:00pm Annual General Meeting
10/20/17 Q1 2018 Sales and Revenue Release - Interim Management Statement
10/19/17 BCVA Conference
10/13/17 BVZS Conference
Upcoming sector events for DECHRA PHARMACEUTICALS PLC
10/22/17 | 02:00pm MERCK & CO., INC. : Liver Meeting - Abstract 1568
10/22/17 | 02:00pm MERCK & CO., INC. : American Association for the Study of Liver Diseases Liver Meeting - Abstract 1589
10/22/17 | 02:00pm MERCK & CO., INC. : American Association for the Study of Liver Diseases Liver Meeting - Abstract 1546
10/22/17 | 02:00pm MERCK & CO., INC. : American Association for the Study of Liver Diseases Liver Meeting - Abstract 1568
Past sector events for DECHRA PHARMACEUTICALS PLC
10/21/17 | 08:00pm MERCK & CO., INC. : American Association for the Study of Liver Diseases Liver Meeting - Abstract 976
10/21/17 | 08:00pm MERCK & CO., INC. : American Association for the Study of Liver Diseases Liver Meeting - Abstract - 1124
10/21/17 | 08:00pm MERCK & CO., INC. : Liver Meeting - Abstract 1113
10/21/17 | 08:00pm MERCK & CO., INC. : American Association for the Study of Liver Diseases Liver Meeting - Abstract 1113
Annual publications
Previous yearNext Year
Annual results2015201620172018 (e)2019 (e)
Sales
Million GBP
Released
Forecast
Spread
204
204
-0,03%
248
237
4,5%
359
364
-1,4%

397

431
Operating income (EBITDA)
Million GBP
Released
Forecast
Spread
48,0
48,3
-0,67%
58,0
57,2
1,4%
86,3
88,3
-2,3%

102

113
Operating profit (EBIT)
Million GBP
Released
Forecast
Spread
44,4
39,8
11%
52,9
45,2
17%
81,3
73,7
10%

88,1

98,9
Pre-Tax Profit (EBT)
Million GBP
Released
Forecast
Spread
25,8
25,1
2,8%
14,5
30,7
-53%
28,6
36,9
-23%

53,1

64,8
Net income
Million GBP
Released
Forecast
Spread
19,5
21,6
-10%
12,5
19,5
-36%
26,1
29,5
-12%

40,4

50,2
EPS
PNC
Released
Forecast
Spread
22,0
24,5
-10%
13,9
28,8
-52%
27,9
30,0
-7,0%

50,8

61,3
Announcement Date09/07/201509/05/201609/04/2017

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsS1
2017
S2
2017
Sales
Million GBP
Released
Forecast
Spread
173
170
1,7%
187

Operating income (EBITDA)
 GBP
Released
Forecast
Spread




Operating profit (EBIT)
 GBP
Released
Forecast
Spread




Pre-Tax Profit (EBT)
 GBP
Released
Forecast
Spread




Net income
Million GBP
Released
Forecast
Spread


13,4

EPS
PNC
Released
Forecast
Spread


14,3

Announcement Date02/27/201709/04/2017

© 2017 Thomson Reuters
© 2017 Factset
Net sales (Year) - Rate of surprise
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise